Wird geladen...
Role of Direct Oral Anticoagulants in Patients with Kidney Disease
The anticoagulation field is experiencing a renaissance that began with regulatory approval of the direct thrombin inhibitor, dabigatran, a Direct Oral Anticoagulant (DOAC) in 2010. The DOAC medication class has rapidly evolved to include the additional approval of four direct factor Xa inhibitors....
Gespeichert in:
| Veröffentlicht in: | Kidney Int |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7093256/ https://ncbi.nlm.nih.gov/pubmed/32107019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2019.11.027 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|